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This was a retrospective, descriptive and documental study with the aim of identifying 
adverse drug events which occurred in the medication administration process and to classify 
these medication errors. This study was developed in the internal medicine unit of a general 
hospital of Goiás, Brazil. Report books used by nursing staff from the period 2002 to 2007, 
were analyzed. A total of 230 medication errors were identified, most of which occurred in 
the preparation and administration of the medications (64.3%). Medication errors were of 
omission (50.9%), of dose (16.5%), of schedule (13.5%) and of administration technique 
(12.2%) and were more frequent with antineoplastic and immunomodulating agents 
(24.3%) and anti-infective agents (20.9%). It was found that 37.4% of drugs were high 
alert medications. Considering the medication errors detected it is important to promote a 
culture of safety in the hospital.
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Eventos adversos a medicamentos em um hospital sentinela do Estado 
de Goiás, Brasil
Trata-se de estudo retrospectivo, documental e descritivo que teve como objetivo 
identificar os eventos adversos a medicamentos, ocorridos no processo administração 
de medicamentos, e classificar os erros de medicação. Este estudo foi desenvolvido na 
unidade de clínica médica de um hospital geral de Goiás, Brasil. Foram analisados os 
livros utilizados pela equipe de enfermagem, no período de 2002 a 2007, para registros 
de passagem de plantão. Identificaram-se 230 erros de medicação, sendo a maioria no 
preparo e administração de medicamentos (64,3%). Os erros de medicação foram de 
omissão (50,9%), de dose (16,5%), de horário (13,5%) e de técnica de administração 
(12,2%), sendo mais frequentes com antineoplásicos e imunomoduladores (24,3%) e anti-
infecciosos (20,9%). Constatou-se que 37,4% dos medicamentos eram potencialmente 
perigosos. Considerando os erros de medicação detectados, é importante promover 
cultura de segurança no hospital.
Descritores: Qualidade da Assistência à Saúde; Gerenciamento de Segurança; Erros de 
Medicação.
Eventos adversos causados por medicamentos en un hospital centinela 
del Estado de Goiás, Brasil
Se trata de un estudio retrospectivo, documental y descriptivo que tuvo como objetivo 
identificar los eventos adversos causados por medicamentos ocurridos en el proceso de 
administrarlos y clasificar los errores de medicación. Este estudio fue desarrollado en 
la unidad de clínica médica de un hospital general de Goiás, Brasil. Fueron analizados 
los libros utilizados por el equipo de enfermería, en el período de 2002 a 2007, en 
los registros de traspaso de plantón. Fueron identificados 230 errores de medicación, 
siendo la mayoría en la preparación y administración de medicamentos (64,3%). Los 
errores de medicación fueron de omisión (50,9%), de dosis (16,5%), de horario (13,5%) 
y de técnica de administración (12,2%), siendo más frecuentes con antineoplásicos e 
inmunomoduladores (24,3%) y antiinfecciosos (20,9%). Se constató que 37,4% de los 
medicamentos eran potencialmente peligrosos. Considerando los errores de medicación 
detectados es importante promover una cultura de seguridad en el hospital.
Descriptores: Calidad de la Atención de Salud, Administración de la Seguridad; Errores 
de Medicación.
Introduction
Adverse drug events (ADEs) have been the focus 
of studies in various countries, because they occur 
frequently and increase the morbidity and mortality 
of patients, becoming new public health problem(1). 
Adverse drug events (ADEs) cover the adverse reaction 
to medication (ADR) and medication errors (ME). ME 
is one of the most frequent types of ADE and has as 
characteristics the fact that it can be avoided, can occur 
at any stage of the medication system (prescribing, 
dispensing and administration of medication) and 
with any professional of the multidisciplinary team 
responsible for actions aimed at drug therapy: 
physicians, pharmacists and nurses(1-2).
The World Health Organization has encouraged all 
countries in the world to pay more attention to ADEs and 
patient safety and, in many countries, the discussions 
and implementation of strategies relating to this thematic 
are already well advanced. One of the first actions has 
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been to encourage the systematization of the collection 
of detailed information about ADEs, to be analyzed with 
the aim of planning and implementation of strategies to 
reduce similar incidents in the future(3).
Internationally, over the past years in several 
countries, policies and practices for public reporting 
of ADEs, including MEs, have been developed and 
implemented. In Brazil, the identification, classification 
and analysis of ADEs occurring in hospitals are poorly 
disclosed and governmental actions for the safety 
of patients are still very tentative, since there are no 
estimates on the incidence of MEs, their consequences, 
their causes, nor the direct and indirect costs of these 
errors for healthcare organizations. Discussions are just 
beginning, considering that in 2001, a network of sentinel 
hospitals was established by the Ministry of Health, 
through the National Agency for Sanitary Surveillance 
(ANVISA), which were prepared for reporting adverse 
events and technical complaints regarding health 
products. However, there is no national database to 
receive and analyze such events, as few hospitals have 
a formal system for reporting and analyzing errors.
An overview of the national reality was provided by 
a pioneer study in three hospitals in Rio de Janeiro which 
identified a rate of 5.6% of ADEs(4). The current reality 
is that many hospitals only identify serious ADEs, which 
cause great harm to the patient and thereby become 
public domain. ADEs considered of lesser proportion 
are not notified due to the lack of procedures aimed at 
identifying, reporting and recording them, or from fear 
of exposure and punishment. Ignorance of the rate of 
ADEs makes it impossible for managers to scale the 
additional costs imposed on the organization, such 
as increased length of stay, the request for additional 
examinations and drugs, not to mention the possibility 
of procedural actions brought by injured clients. In this 
context, each hospital must seek information regarding 
ADEs and MEs and build their own databases with the 
types, frequencies and causes(5) seeking to transform 
them into practical improvements to the system through 
quality programs(6).
There are several ways to identify ADEs in 
hospitals such as: formal systems of notification of 
MEs, retrospective review of medical records, direct 
observation, anonymous reporting combined with 
observation, analysis of administrative data and 
interviews with patients and health professionals(5,7). 
Given the scarcity of formal notification systems in 
hospitals, the sources of information based on notes 
describing the assistance that was provided, the clinical 
evolution, complaints and requests are considered 
adequate to detect ADEs(5). When written in a way that 
portrays the reality, the nursing notes enable ongoing 
communication that may be intended for different 
purposes (research, audit, legal processes, planning and 
others) in addition to providing important information on 
the quality of care.
Considering that the nursing team remains full 
time at the hospital, accompanying the patient and 
that evidence has demonstrated that this professional 
category is the one that most reports incidents among 
health professionals(5), it is believed that the records, 
books, events, made by this team constitute a potential 
source for identification of ADEs. In this light the objective 
was to identify in the nursing records of a hospital ward, 
ADEs that occurred in the process of preparation and 
administration of medications and classify the MEs 
detected.
Method
This was a retrospective, documental, descriptive 
study with an exploratory design, developed in the 
Internal Medicine Unit of a general hospital in Goias. 
The choice of this institution is due to it being part of 
the Network of Sentinel Hospitals of the National Agency 
for Sanitary Vigilance and being an area of formation of 
human resources in health. This hospital gives priority 
to care, education, research and extramural activities, 
and is the internship site for various health professional 
formation centers. It has about three hundred beds, 
reserved exclusively for patients of the National Health 
System, in various clinical and surgical specialties. 
The internal medicine unit was selected because it has 
59 beds distributed over thirteen wards with various 
specialties that treat patients with chronic diseases. 
It is noteworthy that the institution investigated does 
not have a notification system for adverse events and 
their distribution system of medication is the direct 
individualized drug-dispensing system, with the use of 
carbon paper copies of the prescription.
Data were obtained from the books used by 
nursing staff, mainly nurses, in the period 2002 
to 2007, which contained shift reports, warnings, 
internal communications, requests and annotation of 
intercurrences. The unit of analysis was the nursing 
register. We analyzed the content of the notes to 
identify the records related to the occurrence of ADEs. 
Information concerning the adverse event and the drug 
involved was recorded in a data collection instrument 
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developed by the researchers. The collection was 
performed in 2007 and 2008 and the sample comprised 
all 242 notes related to drugs, described in the nursing 
book of the analysis period.
The pharmacological classification of drugs was 
performed according to the Anatomical Therapeutic 
Chemical Classification System (ATC) (level 1 – 
anatomical group) of the “WHO Collaborating Centre 
for Drug Statistics Methodology”, an organ of the World 
Health Organization(8). The ATC classification, widely 
used in pharmacoepidemiology, is important because 
it provides comparison with other investigations 
and ensures uniformity in the determination of the 
therapeutic classes. The drugs with a narrow therapeutic 
index were identified in tertiary source of reference in 
pharmacotherapy(9). High alert medications - HAMs were 
classified according to the Institute for Safe Medication 
Practice (ISMP)(10).
The errors were classified according to the American 
Society of Hospital Pharmacists (ASHP)(11). The ASHP 
classifies medication errors as error of prescription 
(incorrect drug selection, dose, route, concentration, 
speed of administration, prescription illegible or 
prescribed orientations that allow errors that harm the 
patient); error of omission (failure in the administration 
of a prescribed dose to a patient before the next, if any); 
error of schedule (administration of medication outside 
a predefined interval of time of the administration 
schedule), error of unauthorized medication 
(administration of medication not prescribed); error of 
dose (administration of a higher or lower dosage or the 
prescribed dose in duplicate); error in preparation of the 
medication (drug formulated or manipulated incorrectly 
before administration); error of administration 
technique (procedure inappropriate or administration 
technique inappropriate); error of drug deterioration 
(administration of medication past the expiration date 
or when its physical or chemical integrity has been 
compromised); error of monitoring (failure in the review 
of a prescribed regimen to detect problems or failures 
in the use of laboratory or clinical data to identify the 
appropriate response of a patient to the therapy); error 
of adhesion (inadequate behavior of the patient with 
regard to adherence to a of prescribed drug regimen) 
and other errors (any error other than those cited in the 
categories listed previously).
The collected data were entered into a database 
developed using Epidata 3.1 with validation and 
consistency checking. Univariate descriptive statistical 
analysis employing SPSS 15.0 software was performed. 
The study was conducted after approval by the Research 
Ethics Committee and authorization from the hospital 
management.
Results
After the content analysis of the 242 records 
related to drugs it was found that 230 (95.1%) notes 
had complete information related to the ADE, allowing 
classification of these. Just one note was related to the 
ADR and was not included in the sample due to insufficient 
information. The ADEs identified were 230 medication 
errors (MEs). It is noteworthy that some notes provided 
information about errors with more than one drug for 
the same patient or errors of the same medication for 
various patients. In the temporal evolution analysis of 
the quantity of ADEs an increase was identified in the 
numbers of MEs of 247.4% in 2004 due to the rise from 
19 in 2002 to 66 in 2004, as shown in Figure 1.
Figure 1 – Annual evolution of the number of medication errors reported in nursing records
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Among the types of MEs classified according to 
the ASHP(11) the frequency of errors of omission (117; 
50.9%); dose errors (38; 16.5%) and schedule errors 
(31; 13, 5%), are highlighted. Table 1 shows the 
distribution of medication errors identified in the study.
Table 1 – Distribution of MEs reported in the nursing 
occurrence book classified according to the ASHP(11). 
Goiás, Brazil, 2008
Type of Error n %
Error of omission 117 50.9
Dose error 38 16.5
Error of schedule 31 13.5
Error of administration technique 28 12.2
Error of unauthorized medication 15 6.5
Error of preparation 01 0.4
Total 230 100
The distribution of MEs according to the subsystems 
of medication were: preparation and administration of 
medications (148; 64.3%), dispensing (59; 25.6%) and 
prescription (23; 10.1%).
Table 2 – Characteristics of the medications involved in 
MEs Goiás, Brazil, 2008
Characteristics n %
Route of administration of medication 
Parenteral 153 66.5
Oral 38 16.5
Pulmonary  36 0.9




L – Antineoplastic and immunomodulating agents 56 24.3
J – Anti-infective agents for systemic use 48 20.9
B – Blood and Hematopoietic Organs 35 15.3
A – Alimentary Tract and Metabolism 24 10.4
C – Cardiovascular System 21 9.1
N – Nervous System 10 4.3
V – Various 05 2.2
H – Systemic Hormonal preparations, excluding sex 
hormones and insulins 04 1.7
P – Antiparasitic products, insecticides and 
repellents 02 0.9
R – Respiratory System 03 1.3
Report did not permit identification of the ATC class 22 9.6
Total 230 100
Low therapeutic index Pharmaceuticals 99 43.0
High Alert Medications 86 37.4
Table 2 presents the characteristics of the drugs 
involved in MEs. The level 1 groups of the ATC of drugs 
with greater frequency of MEs were the antineoplastic 
and immunomodulating agents (56; 24.3%), anti-
infective agents for systemic use (48; 20.9%) and blood 
and hematopoietic organs (35; 15.3 %). Regarding the 
therapeutic index, 43.0% of the drugs involved in MEs 
had a low index.
The frequency of potentially dangerous medications 
was 37.4% and the errors involving parenteral drugs 
accounted for 66.5%.
The records found and analyzed did not allow the 
identification of the consequences and the actions taken 
by the team in most of the reported adverse events.
Discussion
The results of this study showed the potential of 
nursing records as a source of information regarding 
ADEs and the applicability of this potential in the 
situational diagnostic, in the risk analysis and in the 
implementation of improvements to increase patient 
safety with regard to pharmacotherapy, because 93.9% 
of reports where the content was relative to medication, 
had information about ADEs.
In the literature investigated no study was identified 
that exclusively employed the nursing records as a 
source for identifying ADEs. However, a comparative 
study of sources of information about patient safety 
showed that ME was the incident most detected on the 
basis of written records of critical incidents (20.7%) and 
in medical record reports (21.7%)(5), which explains the 
results of this investigation.
The ADEs identified in the nursing records were 
predominantly MEs, and the only ADEs involving an 
ADR was excluded from the study group due to lack of 
information. The nurse in their habitual practice identifies 
and records signs and symptoms of patients, so has 
adequate conditions to report ADRs. The performance 
of the nurse in the reporting of ADRs may be improved 
through educational strategies that demonstrate the 
importance of this attitude for patient safety, as occurred 
in Switzerland, resulting in an increase in notification of 
ADRs by this professional(12).
Analysis of the increase in the number of records in 
2004 showed a high prevalence of occurrences related 
to antineoplastic medication, which occurred due to the 
centralization of the preparation of antineoplastic agents 
in the service pharmacy, with systematic changes in 
their distribution. Considering that the medication 
administration process involves complex organizational 
systems, this complexity, together with the large number 
of drugs administered to patients, creates opportunities 
for errors. Thus, this elevation of MEs can be explained 
by the reference of systems theory that emphasizes that 
any action on part of the system necessarily provokes 
a reaction from the other parts(13). The redirection of 
antineoplastic preparation and lack of communication 
between the subsystems of medication may be factors 
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that contributed to the increase in errors as a function of 
modification to the original system.
Knowledge of the types of errors prevalent in the 
hospital and its subsystems is key to improving their 
medication administration process. In this investigation 
the most frequent errors were errors of omission 
(117;50.9%); dose errors (38;16.5%) and schedule 
errors (31;13.5%).
Although errors are detected in higher proportion 
(148;64.3%) in the subsystem of medication 
administration it is important to highlight the influence 
of errors in other subsystems, such as dispensing 
(59;25.6%) and prescription (23;10.1%), because the 
errors may reflect the malfunction of the medication 
system as a whole. It is noteworthy that often the 
determinant of the error is present in more than one 
subsystem. In analyzing the content of the records of 
errors classified as errors of omission and of schedule 
it was identified that they were related not only to 
factors intrinsic to the nursing team but also to factors 
associated with the distribution of medications by the 
pharmacy and the prescribers (inadequate filling of 
control forms especially for antimicrobial agents), 
emphasizing the importance of the systemic approach 
to optimize security in pharmacotherapy. These results 
reflect the need to optimize the medication systems of 
hospital institutions, reviewing the subsystems, reducing 
steps and simplifying the processes, aiming to reduce 
medication errors.
Lack of drugs was the main determinant of the 
errors of omission. It is important to highlight that the 
unavailability of medication in the hospital pharmacy has 
external and internal determinants for the institution. To 
avoid impacts in the system of medication it is important 
to incorporate modern logistical concepts for materials 
that prevent the shortage of medications due to internal 
factors (inadequate planning or use of inefficient 
management tools). The safety of the care process 
is compromised by the unavailability of medications, 
for MEs and ADRs are more likely when a therapeutic 
approach has to be substituted for reasons unrelated to 
the clinical needs of the patients(14).
The reports of dose errors (38; 16.5%) and errors of 
administration technique (28; 12.2%) reflected situations 
of a lack of knowledge about specific medications and of 
difficulty in handling equipment such as infusion pumps. 
In the category of error of administration technique 
one error with death was detected due to intravenous 
administration of an enteral feeding solution. Prevention 
strategies of such errors include the expansion of 
educational measures aimed at the reality of the unit 
and the adoption of systems of interception of errors(15), 
such as the use of a single model of infusion pump and 
of specific syringes for connection to tubes for enteral 
administration.
The distribution of MEs, considering the 
pharmaceutical form (Table 2), shows that the 
medications more associated with errors were those 
of parenteral use and of oral use. Errors with drugs 
administered by the parenteral route also presented 
high frequencies in other studies. The incidence of errors 
with oral use medications is explained by these being 
the most prescribed in hospitals(16).
For a better comprehension of MEs in relation to 
route of administration it is important to analyze the 
pharmaceutical forms, considering the complexity of 
administration, the risk of damage and the cost. The 
pharmaceutical forms classified as higher complexity 
are, by order, those for intermittent or continuous 
intravenous infusion, those intended for direct 
intravenous administration (bolus) followed by those of 
administration by other routes of parenteral use. The 
forms of solid and liquid oral use are considered less 
complex. Regarding the classification of risk of harm 
to the patient the parenteral forms present major 
damage and are proportional to the complexity. The 
pharmaceutical forms not intended for oral or parenteral 
use are in the classification of lower risk of damage. 
The order of classification in relation to cost is the same 
proposal for the complexity of administration(16).
The complexity of the process of parenteral 
medication administration, involving multiple steps, 
requires a greater need for adjustments and monitoring 
throughout the period of administration, increasing 
the risk of errors(17). To increase safety in medication 
administration, especially for parenteral medications, the 
incorporation of information technology applied to health 
is proposed, through intelligent systems of infusion, bar 
coding, computerized prescribing and decision support 
programs(18).
Analyzing the Level 1 ATC classification, the 
medications of the antineoplastic and immunomodulator 
groups (56; 24.3%), anti-infective agents for systemic 
use (48; 20.9%) and blood and hematopoietic organs 
(35; 15.3%) were the major therapeutic groups 
associated with MEs. The significant frequency of errors 
with antineoplastic agents is a peculiarity of the hospital 
investigated, because the profiles found by other 
researchers refer to a higher frequency of errors with 
antimicrobial agents(2). The concern with MEs involving 
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antimicrobials is increasing in the literature because the 
inappropriate use of this therapeutic class contributes to 
the emergence of microbial resistance(19).
The nurse, to supervise and execute the activities of 
drug administration, requires solid knowledge regarding 
pharmacodynamics, pharmacokinetics, administration 
techniques, adverse reactions, drug interactions 
and monitoring parameters of therapeutic response. 
This knowledge is essential given the diversity of the 
therapeutic arsenal available in hospitals, which grows 
every day with the incorporation of new therapeutic 
classes, new pharmaceutical forms and new drug 
delivery systems, constituting a risk factor for MEs(2). 
The periodic professional update is an adequate antidote 
to the problem, reducing the gap between the knowledge 
of the nursing professionals and the demand for their 
performance in the practice of drug therapy(20).
The lack of knowledge about aspects of 
pharmacotherapy arises primarily from faulty training 
in pharmacology applied to practice. Pharmacokinetic 
aspects, such as the issue of drugs with narrow 
therapeutic indices, are taught during the graduation 
without correlation with the issue of ME and risks to 
patient safety. The same happens with the pattern of 
ADRs, the intensity of the pharmacodynamic effect and 
other issues relevant to pharmacotherapy, primarily of 
high alert medications(2,20).
Although most drugs have a safe therapeutic margin, 
there are drugs that present an inherent risk of harm to 
patients when there is failure in their utilization process. 
These medications are called high alert medications 
(HAMs). The errors that occur with these drugs are not 
the more routine, but when they occur, they present high 
severity and can lead to permanent injury or may be 
fatal(10). In this study the percentage of errors with HAMs 
was 37.4%, with the high prevalence of antineoplastic 
agents. Other frequent HAMs were heparin, insulin, 
enoxaparin and phenprocoumon. When there is a desire 
to implement a program for prevention of MEs, one of 
the groups of drugs that may have preference in this 
choice are the HAMs(10).
In Internal Medicine Units is also important to identify 
the errors with medications with narrow therapeutic 
indices (MNTIs). The group of MNTIs is comprehensive 
encompassing some HAMs, certain antibiotics and other 
drugs, many of oral use. They are medications where the 
difference between therapeutic and toxic concentrations 
is very small, necessitating careful monitoring of the 
dose, of the clinical effects and, sometimes, of the blood 
concentrations. Especially in the elderly, the errors 
with these medications can result in hospitalization 
or prolongation of the hospital stay, when they occur 
during hospitalization(20). The frequency of errors with 
MNTIs was 43%. In the study group the mistakes with 
the following MNTIs highlighted: antineoplastic drugs, 
heparin, vancomycin, and phenytoin.
The errors of schedule and dose identified in this 
study should be analyzed carefully. In the case of MNTIs 
or HAMs these types of errors are worrying, because the 
safety margin is small. In the case of MNTIs they may 
generate an error cascade, if it occurs near the day of 
the plasma monitoring exam. Due to a medication error, 
the plasma level does not reflect the clinical context of 
the patient and can lead the physician to perform an 
inappropriate posological adjustments that may expose 
the patient to a new adverse event. The errors with HAMs 
and MNTIs identified in the study represent a threat to 
safety from using medications, thus, the implementation 
is recommended of preventive measures, systemic in 
nature, directed at these groups.
The fact that the records did not indicate what the 
consequences were of most events, nor the conduct 
taken as a consequence of what occurred, points to 
the importance of hospitals having their own system 
specifically for this purpose, for a multidisciplinary team 
to execute a deep and thorough analysis of existing 
problems.
Conclusion
The present study identified some of the ADEs 
that occurred in a hospital institution which had a 
multifactorial and multidisciplinary nature, involving 
critical medications in relation to patient safety. It also 
revealed that three adverse events occur on average 
per month in just one of the inpatient units and that 
this is a fact to be faced with transparency and with 
the adoption of urgent actions to correct the existing 
problems and to construct a medication system safer for 
everyone. The nursing team are also alerted to the form 
and content of their notes. Although the records found 
were incomplete preventing a detailed analysis of the 
ADEs, this study indicates that in the case of hospitals 
that have no formal system of notification, the nursing 
notes constitute a form of written communication of 
relevant information and may constitute a starting point 
of the search for and analysis of ADEs.
Given the errors encountered it is believed that 
hospitals should direct efforts to construct a culture 
of safety focused on the patient, within which all 
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professionals involved in the medication system are 
conscious of the need for identification, notification and 
prevention of MEs and that they do this with freedom 
and systematization, expressing in an open, objective 
and complete way what happened and how it happened. 
The notification policy adopted needs to be confidential, 
through anonymous reporting, so that there is no 
search for responsibilities and blame, because a punitive 
culture tends to favor underreporting. It is important to 
construct a database with information on the frequency, 
characteristics and causal factors of errors, which may 
aid in the historical analysis of the incidence of the 
ADEs. The findings should be disseminated and shared 
among the various professionals and the various clinics, 
transforming the errors of one into learning for others, 
seeking improvements to the system.
It is also necessary that a patient safety committee 
is instituted in which a multidisciplinary team leads 
the search for ADEs and adopts methodologies for the 
analysis of risks to which the patients are exposed, 
aiming to implement strategies that serve as barriers 
of protection and prevention of ADEs within the work 
process. Although many of the reported errors do not 
bring serious consequences to patients, they should 
be studied to prevent them happening again and 
contributing to an increase in the hospital stay, leaving 
sequels or even leading to death. It also becomes 
essential that hospitals value the aspects of continued 
training of its professionals in the pharmacological issues 
in care practice.
The limitations of this study should be noted, i.e. 
the sampling from a single hospital, restricting the 
generalization of the results. It is suggested, therefore, 
to replicate this research in other hospitals, of different 
complexities, to increase knowledge of nursing records 
as a source of information for ADEs and their applicability 
in patient safety programs.
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